Difference between revisions of "Part:BBa K4361305"
(3 intermediate revisions by 2 users not shown) | |||
Line 11: | Line 11: | ||
<!-- --> | <!-- --> | ||
− | <span class='h3bb'>Sequence and Features</span> | + | <span class='h3bb'><h3>Sequence and Features</h3></span> |
<partinfo>BBa_K4361305 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4361305 SequenceAndFeatures</partinfo> | ||
+ | <html> | ||
+ | <h3>Usage and Biology</h3> | ||
+ | The set of BlcR mutants (</html>[[Part:BBa_K4361300]] through [[Part:BBa_K4361319]]<html>) were expressed in a PURE system in the presence of GreenLys (fluorescent Cy2-labeled lysine). Samples were then run on an SDS PAGE gel (<b>Figure 1.</b>) to determine whether or not the protein was produced. For this mutant (<u>lane 6</u>), a band was visible on the gel corresponding to BlcR, concluding that the production was successful for this mutant. | ||
+ | |||
+ | <figure> | ||
+ | <a href="https://static.igem.wiki/teams/4361/wiki/results/figure-7-pure/figure-7-pure-6.png"><img src="https://static.igem.wiki/teams/4361/wiki/results/figure-7-pure/figure-7-pure-6.png" style="width:600px;margin-left:125px"></a> | ||
+ | <figcaption> <b>Figure 1.</b> SDS PAGE showing the translation products of 20 different plasmids coding for BlcR mutants. PURE reaction solution was supplemented with GreenLys and the synthesized proteins were imaged with Typhoon using a 488-nm laser. C: negative control with no plasmid. WT: positive control with expressed wildtype BlcR. 6: A62I mutant.</figcaption> | ||
+ | </figure> | ||
+ | |||
+ | |||
+ | </html> | ||
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display |
Latest revision as of 18:17, 13 October 2022
BlcR A62I
A mutant of the BlcR protein, created through site-directed mutagenesis with primers R7 (Part:BBa_K4361210) and F7.3 A62I (Part:BBa_K4361213). For this mutant, the alanine in position 62 has been changed to isoleucine by mutating the GCG codon to ATT.
This mutant contains no nucleotide substitutions or indels outside of the targeted site.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 694
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 78
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 589
Usage and Biology
The set of BlcR mutants (Part:BBa_K4361300 through Part:BBa_K4361319) were expressed in a PURE system in the presence of GreenLys (fluorescent Cy2-labeled lysine). Samples were then run on an SDS PAGE gel (Figure 1.) to determine whether or not the protein was produced. For this mutant (lane 6), a band was visible on the gel corresponding to BlcR, concluding that the production was successful for this mutant.